newsfilter
← Latest News
GlobeNewswire·

G1 Therapeutics Added to the Russell 2000® and 3000® Indexes

RESEARCH TRIANGLE PARK, N.C., July 01, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ:GTHX), a commercial-stage oncology company, today announced that the Company has been added to the broad-market Russell